Medtech Leaders Speak Out On Impact of Global Tariffs
By EsqSocial Corporation 06/05/25
Some Medtech companies recently addressed the potential impact of global tariffs in their Q1 2025 earnings calls. Johnson & Johnson and Abbott were among the first to speak on the implications of these tariffs and how their companies are mitigating against associated risks....
By: Knobbe Martens